Year
Edition number
№3 / 2013
Problem-solving articles
Akimkin V.G., Bormashov A.V.
Problems in medical waste disposal in the Russian Federation: State-of-the-art and solution prospects4-9
Epidemic situation
Vorobyev M.V.
The epidemic situation associated with the prevalence of toxicomania in the Russian Federation in 2000-201110-12
Punga V.V., Rusakova L.N., Yakimova M.A., Putova E.V., Izmailova T.V., Erokhin V.V.
Tuberculosis situation monitoring in the Russian areas supervised by the Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences13-16
Original investigations
Kovaleva T.A., Chuikova K.I.
Study of viral load and immune parameters in women with chronic HBV infection in the third trimester of pregnancy17-22
Kaliaskarova K.S., Tuganbekova S.K., Kuzembaeva K.U., Konysbekova A.A., Malova E.S., Glazkova E.Ya., Balmasova I.P., Rybkina A.A., Bunkova E.B., Morozov V.G.
Genotypic profile and dynamics of viral load in patients with chronic hepatitis C during standard antiviral therapy in the representatives of Kazakh and Slavic populations in the Republic of Kazakhstan23-28
Fazylov V.Kh., Chulanov V.P., Manapova E.R., Karandashova I.V., Dolgin V.A., Beshimov A.T.
Determination of interleukin-28B gene polymorphic variants in patients with mixed CHC/HIV infection29-32
Nagoev B.S., Marjokhova A.R.
Time course of changes in some indicators of endogenous intoxication in erysipelas33-39
Pomogaeva A.P., Nosareva O.L., Zhavoronok T.V.
Lipid peroxidation and nonenzymatic antioxidative system in children with pseudotuberculosis40-44
Reviews and lectures
Kostinov M.P., Andreeva N.P., Petrova T.I.
Clinical and epidemiological efficiency of the prevention of pneumococcal infection with vaccine in infants45-52
Exchange of experience
Ferrante S.A., Elbasha E.H.
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Russia53-63
Konstantinov D.Yu., Konstantinova E.A., Popova L.L., Strebkova E.A., Suzdaltsev A.A.
New approaches to optimizing antiviral therapy in patients with chronic hepatitis C and low baseline leukocyte content64-67
Pyadushkina E.A., Andreeva N.S., Omelyanovsky V.V., Avxentyeva M.V., Rebrova O.Yu.
Сlinicoeconomic analysis of the use of kivexa in the first-line antiretroviral therapy of HIV infection in the Russian Federation68-79
Book reviews
Pokrovsky V.I.
V.V. Shkarin, O.V. Kovalishena. Emerging infections: Systematization, problems, prospects80
